77 related articles for article (PubMed ID: 25362514)
1. BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma.
Xiao S; Liu L; Fang M; Zhou X; Peng X; Long J; Lu X
Dig Dis Sci; 2015 Apr; 60(4):910-8. PubMed ID: 25362514
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC).
Bao YX; Cao Q; Yang Y; Mao R; Xiao L; Zhang H; Zhao HR; Wen H
Diagn Pathol; 2013 Dec; 8():197. PubMed ID: 24313979
[TBL] [Abstract][Full Text] [Related]
3. Effect of bromodomain PHD-finger transcription factor (BPTF) on trophoblast epithelial-to-mesenchymal transition.
Pan L; Zhu F; Yu A; Jia C; Tang H; Zhou M; Li M; Jiang S; Li J; Cui Y; Tang L
Gene; 2024 Jul; 914():148405. PubMed ID: 38521110
[TBL] [Abstract][Full Text] [Related]
4. High expression of embryonic stem cell marker SSEA3 confers poor prognosis and promotes epithelial mesenchymal transition in hepatocellular carcinoma.
Hung TH; Huang Y; Yeh CT; Yeh CN; Yu J; Lin CC; Chiou SP; Chiang PY; Hung JT; Yu AL
Biomed J; 2024 Apr; 47(2):100612. PubMed ID: 37290529
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-β signaling.
Mima K; Hayashi H; Kuroki H; Nakagawa S; Okabe H; Chikamoto A; Watanabe M; Beppu T; Baba H
Oncol Lett; 2013 Jan; 5(1):149-154. PubMed ID: 23255911
[TBL] [Abstract][Full Text] [Related]
6. Opportunity knocks for uncovering the new function of an understudied nucleosome remodeling complex member, the bromodomain PHD finger transcription factor, BPTF.
Zahid H; Olson NM; Pomerantz WCK
Curr Opin Chem Biol; 2021 Aug; 63():57-67. PubMed ID: 33706239
[TBL] [Abstract][Full Text] [Related]
7. New inhibitors for the BPTF bromodomain enabled by structural biology and biophysical assay development.
Ycas PD; Zahid H; Chan A; Olson NM; Johnson JA; Talluri SK; Schonbrunn E; Pomerantz WCK
Org Biomol Chem; 2020 Jul; 18(27):5174-5182. PubMed ID: 32588860
[TBL] [Abstract][Full Text] [Related]
8. BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A.
Guo P; Zu S; Han S; Yu W; Xue G; Lu X; Lin H; Zhao X; Lu H; Hua C; Wan X; Ru L; Guo Z; Ge H; Lv K; Zhang G; Deng W; Luo C; Guo W
Redox Biol; 2022 Sep; 55():102418. PubMed ID: 35932692
[TBL] [Abstract][Full Text] [Related]
9. Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumors.
Khan I; Kashani-Sabet M
Clin Exp Metastasis; 2024 Apr; ():. PubMed ID: 38683257
[TBL] [Abstract][Full Text] [Related]
10. The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.
Dar AA; Nosrati M; Bezrookove V; de Semir D; Majid S; Thummala S; Sun V; Tong S; Leong SP; Minor D; Billings PR; Soroceanu L; Debs R; Miller JR; Sagebiel RW; Kashani-Sabet M
J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713167
[TBL] [Abstract][Full Text] [Related]
11. BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis.
Richart L; Carrillo-de Santa Pau E; Río-Machín A; de Andrés MP; Cigudosa JC; Lobo VJS; Real FX
Nat Commun; 2016 Jan; 7():10153. PubMed ID: 26729287
[TBL] [Abstract][Full Text] [Related]
12. Enhancer interaction networks as a means for singular olfactory receptor expression.
Markenscoff-Papadimitriou E; Allen WE; Colquitt BM; Goh T; Murphy KK; Monahan K; Mosley CP; Ahituv N; Lomvardas S
Cell; 2014 Oct; 159(3):543-57. PubMed ID: 25417106
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
[TBL] [Abstract][Full Text] [Related]
14. 1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain.
Demont EH; Bamborough P; Chung CW; Craggs PD; Fallon D; Gordon LJ; Grandi P; Hobbs CI; Hussain J; Jones EJ; Le Gall A; Michon AM; Mitchell DJ; Prinjha RK; Roberts AD; Sheppard RJ; Watson RJ
ACS Med Chem Lett; 2014 Nov; 5(11):1190-5. PubMed ID: 25408830
[TBL] [Abstract][Full Text] [Related]
15. c-MYC partners with BPTF in human cancer.
Richart L; Real FX; Sanchez-Arevalo Lobo VJ
Mol Cell Oncol; 2016 May; 3(3):e1152346. PubMed ID: 27314097
[TBL] [Abstract][Full Text] [Related]
16. FAC1, a novel gene identified with the monoclonal antibody Alz50, is developmentally regulated in human brain.
Bowser R; Giambrone A; Davies P
Dev Neurosci; 1995; 17(1):20-37. PubMed ID: 7621746
[TBL] [Abstract][Full Text] [Related]
17. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
18. BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas.
Dai M; Lu JJ; Guo W; Yu W; Wang Q; Tang R; Tang Z; Xiao Y; Li Z; Sun W; Sun X; Qin Y; Huang W; Deng WG; Wu T
Oncotarget; 2015 Oct; 6(32):33878-92. PubMed ID: 26418899
[TBL] [Abstract][Full Text] [Related]
19. BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target.
Bezrookove V; Khan IA; Nosrati M; Miller JR; McAllister S; Dar AA; Kashani-Sabet M
Front Oncol; 2022; 12():1011173. PubMed ID: 36530982
[TBL] [Abstract][Full Text] [Related]
20. Targeting regulation of VEGF by BPTF in non-small cell lung cancer and its potential clinical significance.
Dai M; Hua C; Wang M; Gao L; Jiang L; Liu Y
Eur J Med Res; 2022 Dec; 27(1):299. PubMed ID: 36529788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
